Asthma and smoking-induced airway disease without spirometric COPD

European Respiratory Journal

Volumn 49, Issue 5, 2017, Pages

  Thomson, Neil C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; MONTELUKAST; THEOPHYLLINE; TIOTROPIUM BROMIDE; TOBACCO SMOKE;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CLINICAL OUTCOME; COMORBIDITY; COUNSELING; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE EXACERBATION; HUMAN; IMAGING; INFLAMMATION; LOW DRUG DOSE; LUNG FUNCTION; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFLAMMATION; REVIEW; SMOKING; SMOKING CESSATION; SPIROMETRY; CIGARETTE SMOKING; COMPLICATION; LUNG; PATHOPHYSIOLOGY; SYNDROME;

ASTHMA; CIGARETTE SMOKING; COMORBIDITY; HUMANS; LUNG; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SMOKING CESSATION; SPIROMETRY; SYNDROME;

EID: 85019095554     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.02061-2016     Document Type: Review

References (121)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2016. www.goldcopd.org Date last accessed: October 5, 2016.
2. Global Initiative for Asthma. Global strategy for asthma management and prevention. 2016. www.ginasthma.org Date last accessed: October 5, 2016.
3. Cazzola M, Rogliani P. Do we really need asthma-COPD overlap syndrome? J Allergy Clin Immunol 2016; 138: 977-983.
4. Postma DS, Rabe KF. The asthma-COPD overlap syndrome. N Engl J Med 2015; 373: 1241-1249.
5. Bateman ED, Reddel HK, van Zyl-Smit RN, et al. The asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases? Lancet Respir Med 2015; 3: 719-728.
6. Christenson SA, Steiling K, van den Berge M, et al. Asthma-COPD overlap: clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015; 191: 758-766.
7. Alshabanat A, Zafari Z, Albanyan O, et al. Asthma and COPD overlap syndrome (ACOS): a systematic review and meta analysis. PLoS One 2015; 10: e0136065.
8. Kumbhare S, Pleasants R, Ohar JA, et al. Characteristics and prevalence of asthma/chronic obstructive pulmonary disease overlap in the United States. Ann Am Thorac Soc 2016; 13: 803-810.
9. To T, Stanojevic S, Moores G, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health 2012; 12: 204.
10. Centers for disease Control and Prevention. Percentage of people with asthma who smoke. 2016. www.cdc.gov/ asthma/asthma-stats/people-who-smoke.htm Date last accessed: October 5, 2016.
11. Mannino DM, Gagnon RC, Petty TL, et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000; 160: 1683-1689.
12. Halldin CN, Doney BC, Hnizdo E. Changes in prevalence of chronic obstructive pulmonary disease and asthma in the US population and associated risk factors. Chron Respir Dis 2015; 12: 47-60.
13. Soriano JB, Davis KJ, Coleman B, et al. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest 2003; 124: 474-481.
14. Tan WC, Bourbeau J, Hernandez P, et al. Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study. Thorax 2014; 69: 709-717.
15. Marsh SE, Travers J, Weatherall M, et al. Proportional classifications of COPD phenotypes. Thorax 2008; 63: 761-767.
16. Regan EA, Lynch DA, Curran-Everett D, et al. Clinical and radiologic disease in smokers with normal spirometry. JAMA Intern Med 2015; 175: 1539-1549.
17. Woodruff PG, Barr RG, Bleecker E, et al. Clinical significance of symptoms in smokers with preserved pulmonary function. N Engl J Med 2016; 374: 1811-1821.
18. Martinez CH, Diaz AA, Meldrum C, et al. Age and small airway imaging abnormalities in subjects with and without airflow in SPIROMICS. Am J Respir Crit Care Med 2017; 195: 464-472.
19. Çolak Y, Afzal S, Nordestgaard BG, et al. Characteristics and prognosis of never-smokers and smokers with asthma in the Copenhagen General Population Study. A prospective cohort study. Am J Respir Crit Care Med 2015; 192: 172-181.
20. Clatworthy J, Price D, Ryan D, et al. The value of self-report assessment of adherence. rhinitis and smoking in relation to asthma control. Prim Care Respir J 2009; 18: 300-305.
21. Thomson NC, Chaudhuri R. Asthma in smokers: challenges and opportunities. Curr Opin Pulm Med 2009; 15: 39-45.
22. Polosa R, Thomson NC. Smoking and asthma: dangerous liaisons. Eur Respir J 2013; 41: 716-726.
23. Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J 2004; 24: 822-833.
24. Tan WC, Hague CJ, Leipsic J, et al. Findings on thoracic computed tomography scans and respiratory outcomes in persons with and without chronic obstructive pulmonary disease: a population-based cohort study. PLoS One 2016; 11: e0166745.
25. Kim T-B, Jang A-S, Kwon H-S, et al. Identification of asthma clusters in two independent Korean adult asthma cohorts. Eur Respir J 2013; 41: 1308-1314.
26. Forey BA, Thornton AJ, Lee PN. Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med 2011; 11: 36-36.
27. Reports of the Surgeon General. The Health Consequences of Smoking: 50 Years of Progress. Atlanta, US Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014.
28. Coogan PF, Castro-Webb N, Yu J, et al. Active and passive smoking and the incidence of asthma in the Black Women's Health Study. Am J Respir Crit Care Med 2015; 191: 168-176.
29. Eisner MD, Anthonisen N, Coultas D, et al. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 182: 693-718.
30. Elbehairy AF, Guenette JA, Faisal A, et al. Mechanisms of exertional dyspnoea in symptomatic smokers without COPD. Eur Respir J 2016; 48: 694-705.
31. Thomson NC, Chaudhuri R, Heaney LG, et al. Clinical outcomes and inflammatory biomarkers in current smokers and exsmokers with severe asthma. J Allergy Clin Immunol 2013; 131: 1008-1016.
32. Chaudhuri R, McSharry C, McCoard A, et al. Role of symptoms and lung function in determining asthma control in smokers with asthma. Allergy 2008; 63: 132-135.
33. Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006; 28: 523-532.
34. Pelkonen M, Notkola IL, Nissinen A, et al. Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men. Chest 2006; 130: 1129-1137.
35. Lange P, Parner J, Vestbo J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339: 1194-1200.
36. Vonk JM, Jongepier H, Panhuysen CI, et al. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax 2003; 58: 322-327.
37. Cerveri I, Cazzoletti L, Corsico AG, et al. The impact of cigarette smoking on asthma: a population-based international cohort study. Int Arch Allergy Immunol 2012; 158: 175-183.
38. Harmsen L, Thomsen SF, Ingebrigtsen T, et al. Chronic mucus hypersecretion: prevalence and risk factors in younger individuals. Int J Tuber Lung Dis 2010; 14: 1052-1058.
39. Thomson NC, Chaudhuri R, Messow CM, et al. Chronic cough and sputum production are associated with worse clinical outcomes in stable asthma. Respir Med 2013; 107: 1501-1508.
40. Martinez CH, Kim V, Chen Y, et al. The clinical impact of non-obstructive chronic bronchitis in current and former smokers. Respir Med 2014; 108: 491-499.
41. Eisner MD, Iribarren C. The influence of cigarette smoking on adult asthma outcomes. Nicotine Tob Res 2007; 9: 53-56.
42. Dransfield MT, Kunisaki KM, Strand MJ, et al. Acute exacerbations and lung function loss in smokers with and without COPD. Am J Respir Crit Care Med 2017; 195: 324-330.
43. Bowler RP, Kim V, Regan E, et al. Prediction of acute respiratory disease in current and former smokers with and without COPD. Chest 2014; 146: 941-950.
44. Murphy VE, Clifton VL, Gibson PG. The effect of cigarette smoking on asthma control during exacerbations in pregnant women. Thorax 2010; 65: 739-744.
45. Kauppi P, Kupiainen H, Lindqvist A, et al. Long-term smoking increases the need for acute care among asthma patients: a case control study. BMC Pulm Med 2014; 14: 119-119.
46. Thomson NC, Chaudhuri R, Spears M, et al. Poor symptom control is associated with reduced CT scan segmental airway lumen area in smokers with asthma. Chest 2015; 147: 735-744.
47. Bhatt SP, Soler X, Wang X, et al. Association between functional small airway disease and FEV1 decline in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2016; 194: 178-184.
48. Dilektasli AG, Porszasz J, Casaburi R, et al. A novel spirometric measure identifies mild COPD unidentified by standard criteria. Chest 2016; 150: 1080-1090.
49. Aanerud M, Carsin A-E, Sunyer J, et al. Interaction between asthma and smoking increases the risk of adult airway obstruction. Eur Respir J 2015; 45: 635-643.
50. Perret JL, Dharmage SC, Matheson MC, et al. The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age. Am J Respir Crit Care Med 2013; 187: 42-48.
51. Hancox RJ, Gray AR, Poulton R, et al. The effect of cigarette smoking on lung function in young adults with asthma. Am J Respir Crit Care Med 2016; 94: 276-284.
52. Thomson NC. Does age of onset of asthma influence the effect of cigarette smoking on lung function? Am J Respir Crit Care Med 2016; 194: 249-250.
53. Thomson NC. Addressing corticosteroid insensitivity in adults with asthma. Expert Rev Respir Med 2016; 10: 137-156.
54. Barnes PJ. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol 2013; 131: 636-645.
55. Heijink I, van Oosterhout A, Kliphuis N, et al. Oxidant-induced corticosteroid unresponsiveness in human bronchial epithelial cells. Thorax 2014; 69: 5-13.
56. Chalmers GW, Macleod KJ, Little SA, et al. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002; 57: 226-230.
57. Tomlinson JE, McMahon AD, Chaudhuri R, et al. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax 2005; 60: 282-287.
58. Chaudhuri R, Livingston E, McMahon AD, et al. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003; 168: 1308-1311.
59. Livingston E, Thomson NC, Chalmers GW. Impact of smoking on asthma therapy: a critical review of clinical evidence. Drugs 2005; 65: 1521-1536.
60. Telenga ED, Kerstjens HA, ten Hacken NH, et al. Inflammation and corticosteroid responsiveness in ex-, current- and never-smoking asthmatics. BMC Pulm Med 2013; 13: 58.
61. Pedersen SE, Bateman ED, Bousquet J, et al. Determinants of response to fluticasone propionate and salmeterol/ fluticasone propionate combination in the Gaining Optimal Asthma controL study. J Allergy Clin Immunol 2007; 120: 1036-1042.
62. Dijkstra A, Vonk JM, Jongepier H, et al. Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex. Thorax 2006; 61: 105-110.
63. Lange P, Scharling H, Ulrik CS, et al. Inhaled corticosteroids and decline of lung function in community residents with asthma. Thorax 2006; 61: 100-104.
64. O'Byrne PM, Lamm CJ, Busse WW, et al. The effects of inhaled budesonide on lung function in smokers and nonsmokers with mild persistent asthma. Chest 2009; 136: 1514-1520.
65. Mannino DM, Davis KJ, DiSantostefano RL. Chronic respiratory disease, comorbid cardiovascular disease and mortality in a representative adult US cohort. Respirology 2013; 18: 1083-1088.
66. Oelsner EC, Hoffman EA, Folsom AR, et al. Association between emphysema-like lung on cardiac computed tomography and mortality in persons without airflow obstruction: a cohort study. Ann Intern Med 2014; 161: 863-873.
67. Ilmarinen P, Tuomisto LE, Niemelä O, et al. Comorbidities and elevated IL-6 associate with negative outcome in adult-onset asthma. Eur Respir J 2016; 48: 1052-1062.
68. Savage JH, Matsui EC, McCormack M, et al. The association between asthma and allergic disease and mortality: a 30-year follow-up study. J Allergy Clin Immunol 2014; 133: 1484-1487.
69. Boulet L, FitzGerald J, McIvor R, et al. Influence of current or former smoking on asthma management and control. Can Respir J 2008; 15: 275-279.
70. Westerhof GA, de Groot JC, Amelink M, et al. Predictors of frequent exacerbations in (ex)smoking and never smoking adults with severe asthma. Respir Med 2016; 118: 122-127.
71. Stampfli MR, Anderson GP. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol 2009; 9: 377-384.
72. Kuschner WG, D'Alessandro A, Wong H, et al. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 1996; 9: 1989-1944.
73. Amin K, Ekberg-Jansson A, Löfdah CG, et al. Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study. Thorax 2003; 58: 135-142.
74. Soltani A, Ewe YP, Lim ZS, et al. Mast cells in COPD airways: relationship to bronchodilator responsiveness and angiogenesis. Eur Respir J 2012; 39: 1361-1367.
75. Berger KI, Pradhan DR, Goldring RM, et al. Distal airway dysfunction identifies pulmonary inflammation in asymptomatic smokers. ERJ Open Res 2016; 2: 00066-2016.
76. Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974; 291: 755-758.
77. Demarche S, Schleich F, Henket M, et al. Detailed analysis of sputum and systemic inflammation in asthma phenotypes: are paucigranulocytic asthmatics really non-inflammatory? BMC Pulm Med 2016; 16: 1-13.
78. McSharry CP, McKay IC, Chaudhuri R, et al. Short and long-term effects of cigarette smoking independently influence exhaled nitric oxide concentration in asthma. J Allergy Clin Immunol 2005; 116: 88-93.
79. Broekema M, ten Hacken NH, Volbeda F, et al. Airway epithelial changes in smokers but not in ex-smokers with asthma. Am J Respir Crit Care Med 2009; 180: 1170-1178.
80. Ravensberg AJ, Slats AM, van Wetering S, et al. CD8+ T cells characterize early smoking-related airway pathology in patients with asthma. Respir Med 2013; 107: 959-966.
81. Price D, Kaplan A, Jones R, et al. Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide. J Asthma Allergy 2015; 8: 1-13.
82. St-Laurent J, Bergeron C, Pagé N, et al. Influence of smoking on airway inflammation and remodelling in asthma. Clin Exp Allergy 2008; 38: 1582-1589.
83. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012; 18: 716-725.
84. Tuomisto LE, Ilmarinen P, Niemelä O, et al. A 12-year prognosis of adult-onset asthma: Seinäjoki Adult Asthma Study. Respir Med 2016; 117: 223-229.
85. Westerhof GA, Vollema EM, Weersink EJ, et al. Predictors for the development of progressive severity in new-onset adult asthma. J Allergy Clin Immunol 2014; 134: 1051-1056.
86. Tan DJ, Walters EH, Perret JL, et al. Clinical and functional differences between early-onset and late-onset adult asthma: a population-based Tasmanian Longitudinal Health Study. Thorax 2016; 71: 981-987.
87. Tan DJ, Walters EH, Perret JL, et al. Age-of-asthma onset as a determinant of different asthma phenotypes in adults: a systematic review and meta-analysis of the literature. Exp Rev Respir Med 2015; 9: 109-123.
88. Tommola M, Ilmarinen P, Tuomisto LE, et al. The effect of smoking on lung function: a clinical study of adult-onset asthma. Eur Respir J 2016; 48: 1298-1306.
89. Chaudhuri R, McSharry C, Heaney LG, et al. Effects of older age and age of asthma onset on clinical and inflammatory variables in severe refractory asthma. Respir Med 2016; 118: 46-52.
90. Meghji Z, Dua B, Watson RM, et al. Allergen inhalation challenge in smoking compared with non-smoking asthmatic subjects. Clin Exp Allergy 2011; 41: 1084-1090.
91. Cahn A, Boyce M, Mistry S, et al. Randomized trial of allergen-induced asthmatic response in smokers and non-smokers: effects of inhaled corticosteroids. Clin Exp Allergy 2015; 45: 1531-1541.
92. Chang JE, Ding D, Martin-Lazaro J, et al. Smoking, environmental tobacco smoke, and aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2012; 108: 14-19.
93. Eriksson J, Ekerljung L, Bossios A, et al. Aspirin-intolerant asthma in the population: prevalence and important determinants. Clin Exp Allergy 2015; 45: 211-219.
94. Gibeon D, Batuwita K, Osmond M, et al. Obesity-associated severe asthma represents a distinct clinical phenotype: analysis of the British Thoracic Society difficult asthma registry patient cohort according to BMI. Chest 2013; 143: 406-414.
95. Holguin F, Bleecker ER, Busse WW, et al. Obesity and asthma: an association modified by age of asthma onset. J Allergy Clin Immunol 2011; 127: 1486-1493.
96. Yawn BP, Rank MA, Bertram SL, et al. Obesity, low levels of physical activity and smoking present opportunities for primary care asthma interventions: an analysis of baseline data from The Asthma Tools Study. NPJ Prim Care Respir Med 2015; 25: 15058.
97. Strine TW, Balluz LS, Ford ES. The associations between smoking, physical inactivity, obesity, and asthma severity in the general US population. J Asthma 2007; 44: 651-658.
98. Gibson PG. Obesity and asthma. Ann Am Thorac Soc 2013; 10: Suppl., S138-S142.
99. Lemière C, Boulet L-P, Chaboillez S, et al. Work-exacerbated asthma and occupational asthma: do they really differ? J Allergy Clin Immunol 2013; 131: 704-710.
100. Maestrelli P, Schlünssen V, Mason P, et al. Contribution of host factors and workplace exposure to the outcome of occupational asthma. Eur Respir Rev 2012; 21: 88-96.
101. Eriksson J, Ekerljung L, Sundblad BM, et al. Cigarette smoking is associated with high prevalence of chronic rhinitis and low prevalence of allergic rhinitis in men. Allergy 2013; 68: 347-354.
102. Kimura H, Konno S, Nakamaru Y, et al. Sinus computed tomographic findings in adult smoking and non-smoking asthmatics: analysis of clinical indices and biomarkers. Ann Am Thorac Soc 2017; 14: 332-341.
103. Taylor G, McNeill A, Girling A, et al. Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ 2014; 348: g1151.
104. Thomson NC. Novel approaches to the management of noneosinophilic asthma. Therap Adv Respir Dis 2016; 10: 211-234.
105. Chaudhuri R, Livingston E, McMahon AD, et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med 2006; 174: 127-133.
106. Livingston E, Chaudhuri R, McMahon AD, et al. Systemic sensitivity to corticosteroids in smokers with asthma. Eur Respir J 2007; 29: 64-71.
107. Westergaard CG, Porsbjerg C, Backer V. The effect of smoking cessation on airway inflammation in young asthma patients. Clin Exp Allergy 2014; 44: 353-361.
108. McLeish AC, Zvolensky MJ. Asthma and cigarette smoking: a review of the empirical literature. J Asthma 2010; 47: 345-361.
109. Vozoris NT, Stanbrook MB. Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Respir Med 2011; 105: 477-484.
110. Eisner MD, Yelin EH, Katz PP, et al. Predictors of cigarette smoking and smoking cessation among adults with asthma. Am J Public Health 2000; 90: 1307-1311.
111. McLeish AC, Farris SG, Johnson AL, et al. Evaluation of smokers with and without asthma in terms of smoking cessation outcome, nicotine withdrawal symptoms, and craving: findings from a self-guided quit attempt. Addict Behav 2016; 63: 149-154.
112. Melzer AC, Feemster LC, Crothers K, et al. Respiratory and bronchitic symptoms predict intention to quit smoking among current smokers with, and at risk for, chronic obstructive pulmonary disease. Ann Am Thorac Soc 2016; 13: 1490-1496.
113. Roche N, Postma DS, Colice G, et al. Differential effects of inhaled corticosteroids in smokers/ex-smokers and nonsmokers with asthma. Am J Respir Crit Care Med 2015; 191: 960-964.
114. Pilcher J, Patel M, Reddel HK, et al. Effect of smoking status on the efficacy of the SMART regimen in high risk asthma. Respirology 2016; 21: 858-866.
115. Clearie KL, McKinlay L, Williamson PA, et al. Fluticasone/salmeterol combination confers benefits in people with asthma who smoke. Chest 2012; 141: 330-338.
116. Kerstjens HA, Engel M, Dahl R, et al. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med 2012; 367: 1198-1207.
117. Spears M, Donnelly I, Jolly L, et al. Effect of low-dose theophylline plus beclometasone on lung function in smokers with asthma: a pilot study. Eur Respir J 2009; 33: 1010-1017.
118. Price D, Popov TA, Bjermer L, et al. Effect of montelukast for treatment of asthma in cigarette smokers. J Allergy Clin Immunol 2013; 131: 763-771.
119. Rodriguez-Roisin R, Han MK, Vestbo J, et al. Chronic respiratory symptoms with normal spirometry: a reliable clinical entity? Am J Respir Crit Care Med 2017; 195: 17-22.
120. Mannino DM. Does undiagnosed chronic obstructive pulmonary disease matter? Am J Respir Crit Care Med 2016; 194: 250-252.
121. Pinto LM, Gupta N, Tan W, et al. Derivation of normative data for the COPD assessment test (CAT). Respir Res 2014; 15: 68-68.